Clinical Trials Browser

Phase 2 × Sorafenib × Plasma cell × Clear all

NCT00253578 2013-01-07

Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

Multiple Myeloma